Jamjoom Pharmaceuticals Factory Company (4015.SR)

SAR 157.4

(-0.51%)

Market Cap (In SAR)

11.01 Billion

Revenue (In SAR)

1.1 Billion

Net Income (In SAR)

292.4 Million

Avg. Volume

257.85 Thousand

Currency
SAR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-202.4
PE
-
EPS
-
Beta Value
0.37488517
ISIN
SA15QGU1UNH6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Tarek Youssef Hosni
Employee Count
-
Website
https://www.jamjoompharma.com
Ipo Date
2023-06-20
Details
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products in the therapeutic areas of ophthalmology, dermatology, gastrointestinal, cardiovascular, central nervous system, over the counter, general medicine, and nutraceuticals/consumer health. The company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.